Early detection testing for uterine or ovarian cancer risk
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks for early signs of uterine (endometrial) or ovarian cancer, especially in people with inherited risk. It may help doctors catch problems earlier, when treatment can be more effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be able to understand the study and sign consent
- Must not have had a hysterectomy (removal of the uterus)
- Must not be pregnant
- Must not be nursing (breastfeeding)
- Must not be undergoing fertility treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device that takes small samples from the uterus during surgery for suspected or confirmed upper reproductive tract cancer. It may help doctors collect better tissue samples safely while you are already having surgery for tumor removal.
This study tests genetic (DNA) information to help doctors identify ovarian or uterine (endometrial) cancer sooner. You may be asked to do this around the time of planned surgery, when tissue is removed and can be checked for genetic clues.
This study tests whether a transvaginal ultrasound can be used as a screening tool for ovarian cancer in women at higher risk. It may help find ovarian cancer earlier in people who have a strong family or personal cancer history.
This study checks whether a sample of fluid from the uterus (uterine lavage) can help detect ovarian or fallopian tube cancer. You may join if you are having certain gynecologic surgeries or, in a smaller group, you have a BRCA1/2 mutation.
This study is testing new blood tests that might help detect ovarian cancer earlier by looking for specific markers. It involves people with suspected ovarian cancer and healthy volunteers, and aims to improve how we diagnose the disease.
This study is testing a blood test that may help find ovarian cancer earlier in people with BRCA1 or BRCA2 gene changes. It involves giving blood samples before and after surgery to remove the ovaries and fallopian tubes, or over several years if you've had a precancerous lesion found.
Hear when a new Diagnoses Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.